These findings are in line with previous results from gene expression analysis and immunohistochemical validation in retrospective melanoma cohorts, where MCM3, together with MCM4 and MCM6, was found to correlate with poor outcome, although only MCM4 and MCM6 remained independent predictors of survival in multivariable analysis [8]. Here, MCM6 is linked to melanoma.